Abilify (aripiprazole), a partial dopamine agonist, is an antipsychotic drug with additional antidepressant qualities. It has been approved for the treatment of schizophrenia, bipolar disorder and depression as an add-on treatment when the main antidepressant is not effective enough...
Source: http://www.medicalnewstoday.com/articles/248385.php
UNISYS CORP MICRON TECHNOLOGY INC WESTERN DIGITAL CORPORATION AGILENT TECHNOLOGIES, INC.
Tidak ada komentar:
Posting Komentar